Results 1 to 10 of about 1,708 (226)
Knowledge, attitude and practices about hemovigilance among practitioners: a cross-sectional study
: Transfusion by blood and blood products forms an important part of treatment. But this is not free from transfusion reactions which may be in the form of fever, rashes, shivering, anaphylaxis or even death.
Roshi, Vishal Tandon
openalex +3 more sources
Hemovigilance and patient safety: analysis of immediate transfusion reactions in elderly
Paola Almeida dos Santos Sobral +2 more
openalex +1 more source
BACKGROUND AND OBJECTIVE: Septic transfusion reactions due to bacterial contamination in platelet concentrates (PCs) are continually reported to hemovigilance (HV) programs.
Meshari I. Alabdullatif
doaj +1 more source
Hemovigilance- Recipient and Donor Reaction Reporting: An Active Surveillance [PDF]
Amruta Ashok Potdar +4 more
openalex +1 more source
Blood Transfusion Service in Nepal
In Nepal, Blood Transfusion Service-related activities have been initiated in a nationally co-ordinated way. The National Blood programme is established under the National Blood Transfusion Policy.
Rekha Manandhar Shrestha
doaj +1 more source
Donor Hemovigilance: Need of the Hour
Delayed off site adverse donor reactions are rare. Here we report a donor who presented with pain and swelling in right shoulder after an off site injury. Evaluation revealed fracture clavicle. These delayed reactions can be mitigated by donor hemovigilance.
openaire +1 more source
Systematic Workup of Transfusion Reactions Reveals Passive Co-Reporting of Handling Errors
Elisabeth Nitsche,1,2 Jan Dreßler,2,* Reinhard Henschler1,* 1Department of Forensic Medicine, Institute of Legal Medicine, University of Leipzig, Leipzig, Saxony, Germany; 2Department of Quality Control, Institute of Transfusion Medicine ...
Nitsche E, Dreßler J, Henschler R
doaj
Background: Hemovigilance stands as a fundamental necessity for the safe transfusion practice. It is an essential component of quality management in transfusion.
Anugya Kushwaha +5 more
doaj +1 more source
The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen‐ultraviolet A pathogen reduction treatment model [PDF]
Laurence Corash, Richard J. Benjamin
openalex +1 more source
Updated hemovigilance data do not show an increased risk of allergic reactions to methylene blue–treated plasma [PDF]
Axel Seltsam, Thomas Mueller
openalex +1 more source

